Global Diabetes Care Devices Market Set to Reach USD 17.87 Billion by 2032, Driven by Technological Advancements and a 6.3% CAGR

NEWARK, Del, Oct. 25, 2024 (GLOBE NEWSWIRE) -- The global diabetes care devices market is set for extraordinary growth, with market value projected to soar from USD 9.7 billion in 2022 to USD 17.

87 billion by 2032. This substantial expansion, marked by a robust Compound Annual Growth Rate (CAGR) of 6.3% from 2022 to 2032, underscores the market’s rapid evolution, driven by key industry trends and technological innovations.

Key Drivers of Market Growth: Rising Diabetes Prevalence: The increasing incidence of diabetes globally, fueled by lifestyle changes, an aging population, and rising obesity rates, is significantly boosting demand for diabetes care devices. As diabetes becomes a major public health concern, the need for accurate and effective monitoring solutions has surged, propelling market expansion. Technological Advancements in Devices: The continuous development of advanced diabetes care devices, such as continuous glucose monitoring (CGM) systems and insulin delivery solutions, is driving market growth.

These innovations offer more efficient, user-friendly, and minimally invasive ways to manage diabetes, enhancing patient outcomes and improving quality of life. Growing Awareness and Early Diagnosis: With increased awareness campaigns about the importance of early diabetes detection and management, more individuals are opting for routine monitoring and adopting advanced care devices. Governments and healthcare organizations are also playing a crucial role by promoting early diagnosis and ensuring access to essential care.

Integration of Artificial Intelligence (AI) and Digital Health Technologies: The incorporation of AI and digital health solutions in diabetes management is revolutionizing the market. AI-driven analytics, personalized care plans, and connected healthcare platforms are enhancing the effectiveness of diabetes care devices, fostering wider adoption and supporting long-term market growth. Favorable Regulatory Environment and Healthcare Policies: Governments across the globe are implementing favorable regulatory policies and providing incentives for the development and adoption of diabetes care devices.

These supportive measures are helping manufacturers introduce innovative products, accelerating market growth. As diabetes continues to impact millions worldwide, the demand for cutting-edge diabetes care devices will remain strong, driving further innovations and growth in the coming decade. Access the Full Report for In-Depth Insights Now! https://www.

futuremarketinsights.com/reports/diabetes-care-devices-market Key Takeaways: Global Diabetes Care Devices Market The global diabetes care devices market is experiencing significant expansion, projected to reach USD 17.87 billion by 2032, with a CAGR of 6.

3%. North America holds the largest market share due to a well-developed healthcare sector, high healthcare spending, and a substantial diabetic population. Rising obesity rates, increasing treatment costs, technological advancements, and new product launches are propelling market growth.

The Asia Pacific region is poised for the highest growth rate, driven by increasing diabetes awareness, changing healthcare landscapes, and rising healthcare spending. Diabetes imposes a substantial financial burden, with average treatment costs per person reaching USD 9,505.60 in the U.

S. Integration of smart devices, AI, and data analytics is driving market innovation and expansion. "We are witnessing a paradigm shift in diabetes care, driven by technological innovation and a growing awareness of the importance of proactive management, As the prevalence of diabetes continues to escalate globally, there's a heightened focus on enhancing the accessibility and effectiveness of diabetes care devices to empower individuals in managing their condition more effectively.

" opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI). Competition Landscape: The diabetic care devices market is moderately fragmented, featuring a mix of major players and generic manufacturers. Leading companies in this sector actively broaden their business portfolios by launching new products, acquiring other firms, enhancing existing technologies, and taking various measures to boost their market presence.

For instance, in August 2016, Roche launched the Accu-Chek Guide blood glucose monitoring device. This innovative product was designed to help users efficiently reach their glucose targets by offering continuous monitoring throughout the day. Key Players in the Diabetes Care Devices Market Abbott Laboratories ACON Laboratories, Inc.

Ascensia Diabetes Care Holdings AG Becton Dickinson and Company Dexcom, Inc. F. Hoffmann-La Roche Ltd Johnson & Johnson Medtronic plc Novo Nordisk A/S Terumo Corporation Key Segments: By Type: Blood glucose monitoring systems Self-monitoring blood glucose monitoring systems Continuous glucose monitoring systems Test strips/Test papers Lancets/Lancing devices Insulin delivery devices Insulin pumps Insulin pens Insulin syringes and needles Diabetes management mobile applications By Patient Care Settings: Hospitals & specialty clinics Self & home care By Region: North America Latin America Europe Asia Pacific MEA Old Source: https://www.

pharmiweb.com/press-release/2023-03-14/diabetes-care-devices-market-is-projected-to-grow-us-1787-billion-by-2032-at-a-rapid-cagr-of-63 German Translation: Der globale Markt für Diabetespflegegeräte steht vor einem außergewöhnlichen Wachstum. Der Marktwert soll von 9,7 Milliarden USD im Jahr 2022 auf 17,87 Milliarden USD im Jahr 2032 steigen.

Diese beträchtliche Expansion, die durch eine robuste durchschnittliche jährliche Wachstumsrate (CAGR) von 6,3 % von 2022 bis 2032 gekennzeichnet ist, unterstreicht die rasante Entwicklung des Marktes, die von wichtigen Branchentrends und technologischen Innovationen angetrieben wird. Wichtige Treiber des Marktwachstums: 1. Steigende Diabetesprävalenz: Die weltweit zunehmende Zahl von Diabeteserkrankungen, die durch Veränderungen des Lebensstils, eine alternde Bevölkerung und steigende Fettleibigkeitsraten begünstigt wird, steigert die Nachfrage nach Diabetespflegegeräten erheblich.

Da Diabetes zu einem großen Problem der öffentlichen Gesundheit wird, ist der Bedarf an genauen und effektiven Überwachungslösungen stark gestiegen, was die Marktexpansion vorantreibt. 2. Technologische Fortschritte bei Geräten: Die kontinuierliche Entwicklung fortschrittlicher Diabetespflegegeräte wie Systeme zur kontinuierlichen Glukoseüberwachung (CGM) und Lösungen zur Insulinabgabe treibt das Marktwachstum voran.

Diese Innovationen bieten effizientere, benutzerfreundlichere und minimalinvasivere Möglichkeiten zur Behandlung von Diabetes, verbessern die Behandlungsergebnisse der Patienten und steigern die Lebensqualität. 3. Wachsendes Bewusstsein und Frühdiagnose: Mit verstärkten Aufklärungskampagnen über die Bedeutung der Früherkennung und Behandlung von Diabetes entscheiden sich immer mehr Menschen für eine routinemäßige Überwachung und den Einsatz moderner Pflegegeräte.

Regierungen und Gesundheitsorganisationen spielen ebenfalls eine entscheidende Rolle, indem sie eine Frühdiagnose fördern und den Zugang zu grundlegender Pflege sicherstellen. 4. Integration von künstlicher Intelligenz (KI) und digitalen Gesundheitstechnologien: Die Einbindung von KI und digitalen Gesundheitslösungen in die Diabetesbehandlung revolutioniert den Markt.

KI-gesteuerte Analysen, personalisierte Pflegepläne und vernetzte Gesundheitsplattformen verbessern die Wirksamkeit von Diabetespflegegeräten, fördern eine breitere Akzeptanz und unterstützen das langfristige Marktwachstum. 5. Günstiges regulatorisches Umfeld und günstige Gesundheitsrichtlinien: Regierungen auf der ganzen Welt setzen günstige Regulierungsrichtlinien um und bieten Anreize für die Entwicklung und Einführung von Diabetespflegegeräten.

Diese unterstützenden Maßnahmen helfen Herstellern bei der Einführung innovativer Produkte und beschleunigen das Marktwachstum. Da Diabetes weltweit weiterhin Millionen von Menschen betrifft, wird die Nachfrage nach hochmodernen Diabetes-Behandlungsgeräten stark bleiben und im kommenden Jahrzehnt weitere Innovationen und Wachstum vorantreiben. Wichtige Erkenntnisse: Weltweiter Markt für Diabetes-Behandlungsgeräte • Der weltweite Markt für Diabetes-Behandlungsgeräte erlebt ein erhebliches Wachstum und soll bis 2032 17,87 Milliarden USD erreichen, mit einer durchschnittlichen jährlichen Wachstumsrate von 6,3 %.

• Nordamerika hält den größten Marktanteil aufgrund eines gut entwickelten Gesundheitssektors, hoher Gesundheitsausgaben und einer beträchtlichen Zahl von Diabetikern. • Steigende Fettleibigkeitsraten, steigende Behandlungskosten, technologische Fortschritte und die Einführung neuer Produkte treiben das Marktwachstum voran. • Der asiatisch-pazifische Raum dürfte aufgrund des zunehmenden Bewusstseins für Diabetes, sich verändernder Gesundheitslandschaften und steigender Gesundheitsausgaben die höchste Wachstumsrate erreichen.

• Diabetes stellt eine erhebliche finanzielle Belastung dar, wobei die durchschnittlichen Behandlungskosten pro Person in den USA 9.505,60 USD erreichen. • Die Integration von intelligenten Geräten, KI und Datenanalyse treibt Marktinnovation und -expansion voran.

"Wir sind Zeugen eines Paradigmenwechsels in der Diabetesbehandlung, der durch technologische Innovationen und ein wachsendes Bewusstsein für die Bedeutung eines proaktiven Managements vorangetrieben wird. Da die Zahl der Diabetespatienten weltweit weiter zunimmt, liegt der Fokus verstärkt auf der Verbesserung der Zugänglichkeit und Wirksamkeit von Diabetesbehandlungsgeräten, um den Betroffenen die Möglichkeit zu geben, ihre Krankheit effektiver zu managen", meint Sabyasachi Ghosh, Associate Vice President bei Future Market Insights (FMI). Wettbewerbslandschaft: Der Markt für Diabetes-Geräte ist mäßig fragmentiert und umfasst eine Mischung aus großen Akteuren und Generikaherstellern.

Führende Unternehmen in diesem Sektor erweitern ihr Geschäftsportfolio aktiv, indem sie neue Produkte auf den Markt bringen, andere Unternehmen übernehmen, bestehende Technologien verbessern und verschiedene Maßnahmen ergreifen, um ihre Marktpräsenz zu stärken. So brachte Roche im August 2016 das Blutzuckermessgerät Accu-Chek Guide auf den Markt. Dieses innovative Produkt wurde entwickelt, um Benutzern dabei zu helfen, ihre Glukoseziele effizient zu erreichen, indem es den ganzen Tag über eine kontinuierliche Überwachung bietet.

Wichtige Akteure auf dem Markt für Diabetes-Geräte • Abbott Laboratories • ACON Laboratories, Inc. • Ascensia Diabetes Care Holdings AG • Becton • Dickinson and Company • Dexcom, Inc. • F.

Hoffmann-La Roche Ltd • Johnson & Johnson • Medtronic plc • Novo Nordisk A/S • Terumo Corporation Wichtige Segmente: Nach Typ: • Blutzuckermesssysteme • Selbstkontrollierende Blutzuckermesssysteme • Kontinuierliche Glukosemesssysteme o Teststreifen/Testpapiere o Lanzetten/Stechhilfen • Insulinverabreichungsgeräte o Insulinpumpen o Insulinpens o Insulinspritzen und -nadeln • Mobile Anwendungen zur Diabetesbehandlung Nach Patientenversorgungseinrichtungen: • Krankenhäuser und Fachkliniken • Selbst- und Heimpflege Nach Region: • Nordamerika • Lateinamerika • Europa • Asien-Pazifik • MEA Authored By: Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation. Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Explore FMI’s related ongoing Coverage on Healthcare Domain: The sales of palliative care market hold a current valuation of US$ 13.45 billion in 2024, demand could rise and equate to a market valuation of US$ 17.73 billion, with a sluggish CAGR of 2.

8% by 2034. The urgent care market size valuation is US$ 26,099.8 million in 2023 and is anticipated to reach US$ 40,828.

4 million by 2033. Global demand for urgent care is expected to increase at a CAGR of 4.6% from 2023 to 2033.

The vision care market share is expected to expand at a decent CAGR of 7.2% during the forecast period. The valuation of the vision care market as of 2023 is US$ 89,596 million, and the market is projected to be valued at US$ 1,78,930.

9 million by 2033. The pet diabetes care devices market demand is capturing a valuation of US$ 2.3 billion in 2023 and is expected to reach US$ 4.

3 billion by 2033. The market is registering a CAGR of 6.2% during the forecast period.

The global obesity-diabetes drugs market growth is estimated to be worth USD 56,739.0 million in 2024 and is projected to reach a value of USD 97,567.47 million by 2034, expanding at a CAGR of 5.

6% over the assessment period. The global pediatric diabetes therapeutic market outlook is set to reach USD 1,633.8 million in 2024.

Projections indicate that the sector is anticipated to elevate to USD 2,612.4 million by 2034. The global ophthalmic lasers market overview are estimated to be worth USD 976.

8 million in 2024 and are anticipated to reach a value of USD 1,561.0 million by 2034. Sales are projected to rise at a CAGR of 4.

8% over the forecast period between 2024 and 2034. The global juvenile idiopathic arthritis diagnostics market trends are estimated to be worth USD 6,284.6 million in 2024 and are anticipated to reach a value of USD 9,302.

8 million by 2034. Sales are projected to rise at a CAGR of 4.0% over the forecast period between 2024 and 2034.

The global high flow ventilators market opportunity are estimated to be worth USD 1.99 billion in 2024 and anticipated to reach a value of USD 3.77 billion by 2034.

Sales are projected to rise at a CAGR of 6.6% over the forecast period between 2024 and 2034. The global dental burs market strategies are estimated to be worth USD 160.

4 million in 2024 and are anticipated to reach a value of USD 312.6 million by 2034. Sales are projected to rise at a CAGR of 6.

9% over the forecast period between 2024 and 2034. About Future Market Insights (FMI) Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market.

FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Contact Us: Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, USA T: +1-347-918-3531 For Sales Enquiries: [email protected] Website: https://www.futuremarketinsights.

com LinkedIn | Twitter | Blogs | YouTube.